Scientific Advisory Board

  • Arjun Balar, MD
    • Associate Professor and Director, Genitourinary Medical Oncology, NYU Langone Perlmutter Cancer Center

  • Manon Cox, PhD
    • ​CEO, NextWaveBio​
    • Former CEO of Protein Sciences Corporation
  • Judy Lieberman, MD PhD
    • Professor & Chair Immunology, Harvard Medical School
    • Chair Cell & Molecular Med., Boston Children's Hospital
  • Eleanor L Ramos, MD
    • CMO/COO, Provention Bio
    • CMO Global Blood Ther., Theraclone & Zymogenetics
  • Gary Steinberg, MD
    • Professor, Director, Goldstein Bladder Cancer Program
    • Chairman SAB Bladder Cancer Advocacy Network
  • Laurence Zitvogel, MD PhD
    • Professor Immuno-Oncology, University of Paris
    • Director, Center for Immunotherapy, IGR Paris

Bio-Informatics Senior Advisor

William Martin, BA
CIO & COO, Epivax Inc.   

William Martin is the principal architect and developer of the EpiMatrix System. Building on the work done in Dr. De Groot’s Brown University laboratory, Mr. Martin has revised and expanded the EpiMatrix toolkit. In addition to developing new and improved predictive matrices for many Class I and Class II HLA alleles, Mr. Martin has developed a suite of protocols, ancillary tools and database structures allowing for fast and efficient analysis of input protein sequences.

Read Bill's full bio here...

© Copyright Epivax Oncology 2019